Mesenchymal stem cell therapy induces glucocorticoid synthesis in colonic mucosa and suppresses radiation-activated T cells: New insights into MSC immunomodulation

Mucosal Immunology

Volumn 7, Issue 3, 2014, Pages 656-669

  Bessout, R ^a   Semont, A ^a   Demarquay, C ^a   Charcosset, A ^a   Benderitter, M ^a   Mathieu, N ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 10; GLUCOCORTICOID; MIFEPRISTONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CORTICOSTERONE RELEASE; EPITHELIZATION; EX VIVO STUDY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROCTITIS; PROTEIN EXPRESSION; RADIATION EXPOSURE; RAT; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THERAPY EFFECT; ANIMAL; BIOLOGICAL THERAPY; BIOSYNTHESIS; COLON; DRUG EFFECTS; IMMUNOLOGY; INTESTINE MUCOSA; LYMPHOCYTE ACTIVATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; RADIATION RESPONSE; RECTUM;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ANIMALS; CELL- AND TISSUE-BASED THERAPY; COLON; GLUCOCORTICOIDS; IMMUNOMODULATION; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MIFEPRISTONE; RATS; RECTUM; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84899563100     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.85     Document Type: Article

References (38)

1. Henson, C. Chronic radiation proctitis: issues surrounding delayed bowel dysfunction post-pelvic radiotherapy and an update on medical treatment. Therap Adv Gastroenterol 3, 359-365 (2010).
2. Andreyev, H.J., Wotherspoon, A., Denham, J.W. & Hauer-Jensen, M. Defining pelvic-radiation disease for the survivorship era. Lancet Oncol 11, 310-312 (2010).
3. Theis, V.S., Sripadam, R., Ramani, V. & Lal, S. Chronic radiation enteritis. Clin Oncol (R Coll Radiol) 22, 70-83 (2010).
4. Wedlake, L.J., Thomas, K., Lalji, A., Blake, P. & Khoo, V.S. et al. Predicting late effects of pelvic radiotherapy: is there a better approach? Int J Radiat Oncol Biol Phys 78, 1163-1170 (2010).
5. Gonzalez, M.A., Gonzalez-Rey, E., Rico, L., Buscher, D. & Delgado, M. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136, 978-989 (2009).
6. Lim, J.H., Kim, J.S., Yoon, I.H., Shin, J.S. & Nam, H.Y. et al. Immunomodulation of delayed-type hypersensitivity responses by mesenchymal stem cells is associated with bystander T cell apoptosis in the draining lymph node. J Immunol 185, 4022-4029 (2010).
7. Ren, G., Zhang, L., Zhao, X., Xu, G. & Zhang, Y. et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2, 141-150 (2008).
8. Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F. & Bonanni, I. et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106, 1755-1761 (2005).
9. Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C. & Hassan, M. et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439-1441 (2004).
10. Karussis, D., Karageorgiou, C., Vaknin-Dembinsky, A., Gowda-Kurkalli, B. & Gomori, J.M. et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 67, 1187-1194 (2010).
11. Sun, L., Wang, D., Liang, J., Zhang, H. & Feng, X. et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 62, 2467-2475 (2010).
12. Jullien, N., Blirando, K., Milliat, F., Sabourin, J.C. & Benderitter, M. et al. Up-regulation of endothelin type a receptor in human and rat radiation proctitis: preclinical therapeutic approach with endothelin receptor blockade. Int J Radiat Oncol Biol Phys 74, 528-538 (2009).
13. Semont, A.,Demarquay,C., Bessout, R.,Durand,C. & Benderitter,M. et al. Mesenchymal stem cell therapy stimulates endogenous host progenitor cells to improve colonic epithelial regeneration. PLoS One 8, e70170 (2013).
14. Blirando, K., Milliat, F., Martelly, I., Sabourin, J.C. & Benderitter, M. et al. Mast cells are an essential component of human radiation proctitis and contribute to experimental colorectal damage in mice. Am J Pathol 178, 640-651 (2011).
15. Linard, C., Marquette, C., Clarencon, D., Galonnier, M., Mathieu, J. & Pennequin, A. et al. Acute ileal inflammatory cytokine response induced by irradiation is modulated by subdiaphragmatic vagotomy. Journal of Neuroimmunology 168, 83-95 (2005).
16. Gonzalez, M.A., Gonzalez-Rey, E., Rico, L., Buscher, D. & Delgado, M. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 60, 1006-1019 (2009).
17. Parekkadan, B., Upadhyay, R., Dunham, J., Iwamoto, Y. & Mizoguchi, E. et al. Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes. Gastroenterology 140, 966-975 (2011).
18. Parekkadan, B., Tilles, A.W. & Yarmush, M.L. Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells 26, 1913-1919 (2008).
19. Cima, I., Corazza, N., Dick, B., Fuhrer, A. & Herren, S. et al. Intestinal epithelial cells synthesize glucocorticoids and regulate T cell activation. J Exp Med 200, 1635-1646 (2004).
20. Lowenberg, M., Verhaar, A.P., Bilderbeek, J., Marle, J. & Buttgereit, F. et al. Glucocorticoids cause rapid dissociation of a T-cell-receptor- associated protein complex containing LCK and FYN. EMBO Rep 7, 1023-1029 (2006).
21. Francois, S., Bensidhoum,M., Mouiseddine, M., Mazurier, C. & Allenet, B. et al. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells 24, 1020-1029 (2006).
22. Semont, A., Mouiseddine, M., Francois, A., Demarquay, C. & Mathieu, N. et al. Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis. Cell Death Differ 17, 952-961 (2010).
23. Meirelles Lda, S., Fontes, A.M., Covas, D.T. & Caplan, A.I. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20, 419-427 (2009).
24. Krampera, M., Cosmi, L., Angeli, R., Pasini, A. & Liotta, F. et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24, 386-398 (2006).
25. Gremy, O., Benderitter, M. & Linard, C. Acute and persisting Th2-like immune response after fractionated colorectal gamma-irradiation. World J Gastroenterology 14, 7075-7085 (2008).
26. Garg, S., Boerma, M., Wang, J., Fu, Q. & Loose, D.S. et al. Influence of sublethal total-body irradiation on immune cell populations in the intestinal mucosa. Radiat Res 173, 469-478 (2010).
27. Billiard, F., Buard, V., Benderitter, M. & Linard, C. Abdominal gammaradiation induces an accumulation of function-impaired regulatory Tcells in the small intestine. Int J Radiat Oncol Biol Phys 80, 869-876 (2011).
28. Reits, E.A., Hodge, J.W., Herberts, C.A.,Groothuis, T.A. & Chakraborty,M. et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 203, 1259-1271 (2006).
29. Takeshima, T., Chamoto, K.,Wakita, D., Ohkuri, T. & Togashi, Y. et al. Local radiation therapy inhibits tumor growth through the generation of tumorspecific CTL: its potentiation by combination with Th1 cell therapy. Cancer Res 70, 2697-2706 (2010).
30. Friedman, E.J. Immune modulation by ionizing radiation and its implications for cancer immunotherapy. Curr Pharm Des 8, 1765-1780 (2002).
31. Ringdén, O., Uzunel, M., Rasmusson, I., Remberger, M. & Sundberg, B. et al. Mesenchymal stem cells for treatment of therapy-resistant graftversus-host disease. Transplantation 81, 1390-1397 (2006).
32. Garcia-Olmo, D., Garcia-Arranz, M., Herreros, D., Pascual, I. & Peiro, C. et al. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48, 1416-1423 (2005).
33. Uccelli, A., Moretta, L. & Pistoia, V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 8, 726-736 (2008).
34. Nemeth, K., Leelahavanichkul, A., Yuen, P.S., Mayer, B. & Parmelee, A. et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15, 42-49 (2009).
35. Yagi, H., Soto-Gutierrez, A., Parekkadan, B., Kitagawa, Y. & Tompkins, R.G. et al. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant 19, 667-679 (2010).
36. Coste, A., Dubuquoy, L., Barnouin, R., Annicotte, J.S. & Magnier, B. et al. LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease. Proc Natl Acad Sci U S A. 104, 13098-13103 (2007).
37. Botrugno, O.A., Fayard, E., Annicotte, J.S., Haby, C. & Brennan, T. et al. Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell 15, 499-509 (2004).
38. Rochefort, G.Y., Delorme, B., Lopez, A., Herault, O. & Bonnet, P. et al. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells 24, 2202-2208 (2006).